Oriental Aromatics: Healthy Q1 FY27 Growth Amidst Margin Pressures

Consolidated revenue for Oriental Aromatics in Q1 FY27 reached Rs 260 crore, marking a robust 15% increase year-on-year. Profit After Tax saw a substantial surge of 402%, climbing to Rs 2.51 crore.

Reader Takeaway: Revenue growth is strong, but margin pressures persist due to raw material costs and overcapacity.

What just happened

Oriental Aromatics announced its financial results for the first quarter of FY27 (ending June 30, 2026). The company posted consolidated revenue of Rs 260 crore, up from Rs 226 crore in the same period last year. EBITDA grew 9.6% to Rs 19.8 crore. The net profit After Tax (PAT) jumped significantly by 402% to Rs 2.51 crore from Rs 0.5 crore in Q1 FY26.

Why this matters

The strong year-on-year revenue growth, driven by increased sales and production volumes, indicates a healthy demand for the company's products. The significant jump in PAT, however, needs to be viewed in the context of raw material cost fluctuations and the operational status of its Mahad facility.

The backstory

Oriental Aromatics operates in the Camphor and Specialty Aroma Ingredients segments. The company has been investing in its Mahad facility, which is currently in the commercialization phase and operating at 50-60% capacity. The aim is to reach 75-80% utilization for the facility to become EBITDA positive.

What changes now

Management has guided for a 10-15% sales growth in the next year and expects an effective tax rate of around 25%. The focus remains on ramping up the Mahad facility's utilization to improve consolidated profitability. Other facilities are operating at higher utilization rates of 85-90%.

Risks to watch

Key risks include volatility in raw material prices, particularly Alpha-Pinene which saw a 70-80% increase. Structural overcapacity in domestic Camphor and Specialty Aroma Ingredients segments limits pricing power. The Mahad facility's inability to fully absorb fixed costs is currently impacting overall margins.

Peer comparison

(No specific peer comparison data was provided in the filing.)

Context metrics (time-bound)

• Consolidated revenue: Rs 260 crore (Q1 FY27) vs Rs 226 crore (Q1 FY26)
• PAT: Rs 2.51 crore (Q1 FY27) vs Rs 0.5 crore (Q1 FY26)
• EBITDA Margin: 7.62% (Q1 FY27) vs 6.89% (Q4 FY26) and 8.01% (Q1 FY26)
• Mahad Facility Utilization: 50-60%
• Other Facilities Utilization: 85-90%

What to track next

Investors should closely monitor the ramp-up of the Mahad facility towards optimal utilization levels. Tracking the company's ability to manage raw material cost inflation and the impact of industry overcapacity on pricing power will be crucial.